Short dapt with clopidogrel has similar effects that of long term dapt
Patients with Acute Coronary Syndrome (ACS) are regarded as having a higher long-term risk of cardiovascular events after percutaneous coronary intervention (PCI) compared with patients with the chronic coronary syndrome (CCS). Therefore, the recommended duration of dual antiplatelet therapy (DAPT) after PCI was longer in patients with ACS than in patients with CCS.
A recent study suggests that clopidogrel monotherapy after 1 to 2 months of DAPT is no better than standard 12 months of DAPT among ACS patients with successful PCI. The study findings were published in the JAMA Cardiology today (March 02, 2022).
For more information check out the full story on the link below:
Short DAPT Followed by Clopidogrel monotherapy No Better Than Long term DAPT: JAMA
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.